Vis enkel innførsel

dc.contributor.authorAndersen, Sarah Hjorth
dc.contributor.authorLupattelli, Angela
dc.contributor.authorHandal, Marte
dc.contributor.authorSpigset, Olav
dc.contributor.authorYstrøm, Eivind
dc.contributor.authorNordeng, Hedvig Marie Egeland
dc.date.accessioned2022-08-01T07:59:03Z
dc.date.available2022-08-01T07:59:03Z
dc.date.created2021-10-01T01:16:06Z
dc.date.issued2021
dc.identifier.citationPharmacoepidemiology and Drug Safety. 2021, 30 (10), 1380-1390.
dc.identifier.issn1053-8569
dc.identifier.urihttps://hdl.handle.net/11250/3009460
dc.language.isoeng
dc.titlePrenatal Exposure to Non-Steroidal Anti-Inflammatory Drugs and Risk of Attention-Deficit/Hyperactivity Disorder - a Follow-Up Study in the Norwegian Mother, Father and Child Cohort
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1380-1390
dc.source.volume30
dc.source.journalPharmacoepidemiology and Drug Safety
dc.source.issue10
dc.identifier.doi10.1002/pds.5250
dc.identifier.cristin1941779
dc.relation.projectNorges forskningsråd: 288083
dc.relation.projectNorges forskningsråd: 262177
dc.relation.projectEU/639377
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel